Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy

American Journal of Cardiology

Volumn 93, Issue 11 SUPPL., 2004, Pages 32-48

  Rajaram, Venkataraman ^a   Pandhya, Sanjay ^a   Patel, Samir ^a   Meyer, Peter M ^a   Goldin, Marshall ^a   Feinstein, Matt J M ^a   Neems, Rachel ^a   Liebson, Philip R ^a   Fiedler, Benjamin M ^a   Macioch, James E ^a   Feinstein, Steven B ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTILIPEMIC AGENT; ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PIOGLITAZONE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TROGLITAZONE;

ARTERY CALCIFICATION; ARTERY INTIMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BRACHIAL ANGIOGRAPHY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPUTER PROGRAM; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE MARKER; DRUG EFFICACY; ECHOCARDIOGRAPHY; ELECTRON BEAM TOMOGRAPHY; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; IMAGE ANALYSIS; IMAGING SYSTEM; METABOLIC SYNDROME X; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; STROKE; ULTRASOUND; VASA VASORUM;

EID: 2642531755     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.02.004     Document Type: Conference Paper

References (89)

1. Department of Health and Human Services, Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2003. Atlanta, GA
2. American Diabetes Association, National diabetes fact sheet. Cost of diabetes in the United States, 2002
3. Haffner S., Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 108:2003;1541-1545
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
5. Scott C.L. Diagnosis, prevention, and intervention for the metabolic syndrome. Am J Cardiol. 92:(suppl):2003;35i-42i
6. Barzilay JI, Spiekerman CF, Kuller LH, Burke GL, Bittner V, Gottdiener JS, Brancati FL, Orchard TJ, O'Leary DH, Savage PJ. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 2001;24:1233-1239
7. Psaty B.M., Furberg C.D., Kuller L.H., Bild D.E., Rautaharju P.M., Polak J.F., Bovill E., Gottdiener J.S. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults the Cardiovascular Health Study. Arch Intern Med. 159:1999;1339-1347
8. Kuller L.H., Velentgas P., Barzilay J., Beauchamp N.J., O'Leary D.H., Savage P.J. Diabetes mellitus subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol. 20:2000;823-829
9. Pasternak R.C., Abrams J., Greenland P., Smaha L.A., Wilson P.W., Houston-Miller N. 34th Bethesda Conference Task force #1 - identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 41:2003;1863-1874
10. Jaffer F.A., O'Donnell C.J., Larson M.G., Chan S.K., Kissinger K.V., Kupka M.J., Salton C., Botnar R.M., Levy D., Manning W.J. Age and sex distribution of subclinical aortic atherosclerosis a magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 22:2002;849-854
11. Kuller L., Borhani N., Furberg C., Gardin J., Manolio T., O'Leary D., Psaty B., Robbins J. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 139:1994;1164-1179
12. Pignoli P., Tremoli E., Poli A., Oreste P., Paoletti R. Intimal plus medial thickness of the arterial wall a direct measurement with ultrasound imaging. Circulation. 74:1986;1399-1406
13. Salonen J.T., Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 87:(suppl):1993;II56-II65
14. Baldassarre D., Amato M., Bondioli A., et al. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke. 31:2000;2426-2430
15. Burke G.L., Evans G.W., Riley W.A., Sharrett A.R., Howard G., Barnes R.W., Rosamond W., Crow R.S., Rautaharju P.M., Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 26:1995;386-391
16. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 340:1999;14-22
17. Kronmal R.A., Smith V.E., O'Leary D.H., et al. Carotid artery measures are strongly associated with left ventricular mass in older adults (a report from the Cardiovascular Health Study). Am J Cardiol. 77:1996;628-633
18. Ferrara L.A., Mancini M., Celentano A., et al. Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients. Study by ultrasound high-resolution B-mode imaging. Arterioscler Thromb. 14:1994;1290-1296
19. Riley W.A., Barnes R.W., Applegate W.B., et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke. 23:1992;1062-1068
20. Geroulakos G., O'Gorman D.J., Kalodiki E., Sheridan D.J., Nicolaides A.N. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J. 15:1994;781-785
21. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction the Rotterdam Study. Circulation. 96:1997;1432-1437
22. Fujiwara S., Emoto M., Komatsu M., Motoyama K., Morioka T., Koyama H., Shoji T., Inaba M., Nishizawa Y. Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients. J Atheroscler Thromb. 10:23:2003;246-252
23. Wagenknecht L.E., Zaccaro D., Espeland M.A., Karter A.J., O'Leary D.H., Haffner S.M. Diabetes and progression of carotid atherosclerosis the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 23:2003;1035-1041
24. Mohan V., Ravikumar R., Shanthi Rani S., Deepa R. Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects the Chennai Urban Population Study (CUPS). Diabetologia. 43:2000;494-499
25. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-269.
26. Stensland-Bugge E, Bonaa KH, Joakimsen O. Reproducibility of ultrasonographically determined intima-media thickness is dependent on arterial wall thickness. The Tromso Study. Stroke 1997;28:1972-1980
27. Linhart A, Gariepy J, Giral P, Levenson J, Simon A. Carotid artery and left ventricular structural relationship in asymptomatic men at risk for cardiovascular disease. Atherosclerosis 1996;127:103-112
28. Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetiere P. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA study. Stroke 1996;27:654-600
29. Gariepy J, Simon A, Massonneau M, Linhart A, Levenson J. Wall thickening of carotid and femoral arteries in male subjects with isolated hypercholesterolemia. PCVMETRA Group. Prevention Cardio-Vasculaire en Medecine du Travail. Atherosclerosis 1995;113:141-151
30. Wendelhag I, Wiklund O, Wikstrand J. Arterial wall thickness in familial hypercholesterolemia. Ultrasound measurement of intima-media thickness in the common carotid artery. Arterioscler Thromb 1992;12:70-71
31. Touboul PJ, Prati P, Scarabin PY, Adrai V, Thibout E, Ducimetiere P. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging. J Hypertens Suppl 1992;10:S37-41
32. Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kastelein J.J., Stalenhoef A.F. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP) a prospective, randomised, double-blind trial. Lancet. 357:2001;577-581
33. Taylor A.J., Kent S.M., Flaherty P.J., Coyle L.C., Markwood T.T., Vernalis M.N. ARBITER Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 106:2002;2055-2060
34. Hodis H.N., Mack W.J., LaBree L., Selzer R.H., Liu C., Alaupovic P., Kwong-Fu H., Azen S.P. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy a randomized controlled clinical trial. Ann Intern Med. 124:1996;548-556
35. Mercuri M., Bond M.G., Sirtori C.R., Veglia F., Crepaldi G., Feruglio F.S., Descovich G., Ricci G., Rubba P., Mancini M., et al. Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med. 101:1996;627-634
36. Salonen R., Nyyssonen K., Porkkala E., Rummukainen J., Belder R., Park J.S., Salonen J.T. Kuopio Atherosclerosis Prevention Study (KAPS) a population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation. 92:1995;1758-1764
37. Byington R.P., Furberg C.D., Crouse J.R. 3rd, Espeland M.A., Bond M.G. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol. 76:(suppl):1995;54C-59C
38. de Groot E., Jukema J.W., van Boven A.J., Reiber J.H., Zwinderman A.H., Lie K.I., Ackerstaff R.A., Bruschke A.V. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries a report from the Regression Growth Evaluation Statin Study. Am J Cardiol. 76:(suppl):1995;40C-46C
39. Furberg CD, Adams HP, Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation 1994;90:1679-1687
40. Blankenhorn D.H., Selzer R.H., Crawford D.W., Barth J.D., Liu C.R., Liu C.H., Mack W.J., Alaupovic P. Beneficial effects of colestipol-niacin therapy on the common carotid artery two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 88:1993;20-28
41. Kastelein J.J., Wiegman A., de Groot E. Surrogate markers of atherosclerosis impact of statins. Atheroscler Suppl. 4:2003;31-36
42. Olsson A.G., Pears J., McKellar J., Mizan J., Raza A. Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. Am J Cardiol. 88:2001;504-508
43. Nathan D.M., Meigs J., Singer D.E. The epidemiology of cardiovascular disease in type 2 diabetes mellitus how sweet it is... or is it? Lancet. 350:(suppl 1):1997;S14-S19
44. Barrett-Connor E. Does hyperglycemia really cause coronary heart disease? Diabetes Care. 20:1997;1620-1623
45. Nathan D.M., Lachin J., Cleary P., Orchard T., Brillon D.J., Backlund J.Y., O'Leary D.H., Genuth S. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 348:2003;2294-2303
46. Minamikawa J., Tanaka S., Yamauchi M., Inoue D., Koshiyama H. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab. 83:1998;1818-1820
47. Koshiyama H., Shimono D., Kuwamura N., Minamikawa J., Nakamura Y. Rapid communication inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab. 86:2001;3452-3456
48. Macioch JE, Patel SN, Bai CJ, Meyer P, Geohas C, Davidson M, Provost JC, Feinstein SB. Contrast-enhanced ultrasound imaging measurement of carotid intimal medial thickness [abstract]. J Am Coll Cardiol 2003;4:318A. Abstract 886-5
49. Macioch JE, Robin J, Liebson PR, Meyer P, Geohas C, Raichlen JS, Davidson MH, Feinstein SB. Effect of contrast enhancement on measurement of carotid artery intimal medial thickness. Am J Vasc Med. In press
50. Wong M., Edelstein J., Wollman J., Bond M.G. Ultrasonic-pathological comparison of the human arterial wall verification of intima-media thickness. Arterioscler Thromb. 13:1993;482-486
51. Mofidi R., Crotty T.B., McCarthy P., Sheehan S.J., Mehigan D., Keaveny T.V. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg. 88:2001;945-950
52. Barger A.C., Beeuwkes R. 3rd, Lainey L.L., Silverman K.J. Hypothesis vasa vasorum and neovascularization of human coronary arteries: a possible role in the pathophysiology of atherosclerosis. N Engl J Med. 310:1984;175-177
53. Williams J.K., Armstrong M.L., Heistad D.D. Vasa vasorum in atherosclerotic coronary arteries responses to vasoactive stimuli and regression of atherosclerosis. Circ Res. 62:1988;515-523
54. Heistad D.D., Marcus M.L., Larsen G.E., Armstrong M.L. Role of vasa vasorum in nourishment of the aortic wall. Am J Physiol. 240:1981;H781-H787
55. Moulton K.S. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep. 3:2001;225-233
56. Folkman J. Angiogenesis. Jaffe E.A. Biology of Endothelial Cells. 1984;412-428 Maritinus Njhoff Publishers, Boston
57. Isner J.M. Cancer and atherosclerosis the broad mandate of angiogenesis. Circulation. 99:1999;1653-1655
58. Kaul S. Myocardial contrast echocardiography basic principles. Prog Cardiovasc Dis. 44:2001;1-11
59. Neems R, Feinstein M, Goldin M, Dainauskas J, Espinoza P, Johnson M, Daniels M, Liebson PR, Macioch JE, Feinstein SB. Real-time contrast enhanced ultrasound imaging of neovascularization within the human carotid plaque [abstract]. Am J Coll Cardiol2004;4:374A
60. Salomaa V., Riley W., Kark J.D., Nardo C., Folsom A.R. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: the ARIC Study. Atherosclerosis Risk in Communities Study. Circulation. 91:1995;1432-1443
61. Oxlund H., Rasmussen L.M., Andreassen T.T., Heickendorff L. Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 32:1989;748-752
62. Suzuki E., Kashiwagi A., Nishio Y., Egawa K., Shimizu S., Maegawa H., Haneda M., Yasuda H., Morikawa S., Inubushi T., Kikkawa R. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care. 24:2001;2107-2114
63. Suzuki E., Egawa K., Nishio Y., Maegawa H., Tsuchiya M., Haneda M., Yasuda H., Morikawa S., Inubushi T., Kashiwagi A. Prevalence and major risk factors of reduced flow volume in lower extremities with normal ankle-brachial index in Japanese patients with type 2 diabetes. Diabetes Care. 26:2003;1764-1769
64. Fowkes F.G., Housley E., Macintyre C.C., Prescott R.J., Ruckley C.V. Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. J Epidemiol Community Health. 42:1988;128-133
65. O'Rourke R.A., Brundage B.H., Froelicher V.F., Greenland P., Grundy S.M., Hachamovitch R., Pohost G.M., Shaw L.J., Weintraub W.S., Winters W.L. Jr. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol. 36:2000;326-340
66. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M. Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 15:1990;827-832
67. Schmermund A., Denktas A.E., Rumberger J.A., Christian T.F., Sheedy P.F. 2nd, Bailey K.R., Schwartz R.S. Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease comparison with cardiac risk factors and radionuclide perfusion imaging. J Am Coll Cardiol. 34:1999;777-786
68. Simons D.B., Schwartz R.S., Edwards W.D., Sheedy P.F., Breen J.F., Rumberger J.A. Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning a quantitative pathologic comparison study. J Am Coll Cardiol. 20:1992;1118-1126
69. Hoff J.A., Quinn L., Sevrukov A., Lipton R.B., Daviglus M., Garside D.B., Ajmere N.K., Gandhi S., Kondos G.T. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol. 41:2003;1008-1012
70. Meigs J.B., Larson M.G., D'Agostino R.B., Levy D., Clouse M.E., Nathan D.M., Wilson P.W., O'Donnell C.J. Coronary artery calcification in type 2 diabetes and insulin resistance the Framingham Offspring Study. Diabetes Care. 25:2002;1313-1319
71. Khaleeli E., Peters S.R., Bobrowsky K., Oudiz R.J., Ko J.Y., Budoff M.J. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease implications for management. Am Heart J. 141:2001;637-644
72. Snell-Bergeon J.K., Hokanson J.E., Jensen L., MacKenzie T., Kinney G., Dabelea D., Eckel R.H., Ehrlich J., Garg S., Rewers M. Progression of coronary artery calcification in type 1 diabetes the importance of glycemic control. Diabetes Care. 26:2003;2923-2928
73. Doherty T.M., Detrano R.C. Coronary arterial calcification as an active process a new perspective on an old problem. Calcif Tissue Int. 54:1994;224-230
74. Bostrom K., Demer L.L. Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr. 10:2000;151-158
75. Achenbach S., Ropers D., Pohle K., Leber A., Thilo C., Knez A., Menendez T., Maeffert R., Kusus M., Regenfus M., et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification a prospective evaluation. Circulation. 106:2002;1077-1082
76. Callister T.Q., Raggi P., Cooil B., Lippolis N.J., Russo D.J. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 339:1998;1972-1978
77. Devries S., Wolfkiel C., Shah V., Chomka E., Rich S. Reproducibility of the measurement of coronary calcium with ultrafast computed tomography. Am J Cardiol. 75:1995;973-975
78. Mao S., Budoff M.J., Bakhsheshi H., Liu S.C. Improved reproducibility of coronary artery calcium scoring by electron beam tomography with a new electrocardiographic trigger method. Invest Radiol. 36:2001;363-367
79. Fayad Z.A., Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 89:2001;305-316
80. Toussaint J.F., LaMuraglia G.M., Southern J.F., Fuster V., Kantor H.L. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 94:1996;932-938
81. Yuan C., Beach K.W., Smith L.H. Jr, Hatsukami T.S. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 98:1998;2666-2671
82. Corti R., Fayad Z.A., Fuster V., Worthley S.G., Helft G., Chesebro J., Mercuri M., Badimon J.J. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 104:2001;249-252
83. Corti R., Fuster V., Fayad Z.A., Worthley S.G., Helft G., Smith D., Weinberger J., Wentzel J., Mizsei G., Mercuri M., Badimon J.J. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 106:2002;2884-2887
84. Fayad Z.A., Nahar T., Fallon J.T., Goldman M., Aguinaldo J.G., Badimon J.J., Shinnar M., Chesebro J.H., Fuster V. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta a comparison with transesophageal echocardiography. Circulation. 101:2000;2503-2509
85. Kang X., Polissar N.L., Han C., Lin E., Yuan C. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI. Magn Reson Med. 44:2000;968-972
86. Chan S.K., Jaffer F.A., Botnar R.M., Kissinger K.V., Goepfert L., Chuang M.L., O'Donnell C.J., Levy D., Manning W.J. Scan reproducibility of magnetic resonance imaging assessment of aortic atherosclerosis burden. J Cardiovasc Magn Reson. 3:2001;331-338
87. Cai J.M., Hatsukami T.S., Ferguson M.S., Small R., Polissar N.L., Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 106:2002;1368-1373
88. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566
89. Hirayama H., Sugano M., Abe N., Yonemoch H., Makino N. Troglitazone, an antidiabetic drug, improves left ventricular mass and diastolic function in normotensive diabetic patients. Int J Cardiol. 77:2001;75-79